Hélène Aubert, Nizar Mahlaoui, Sébastien Barbarot, Mickaël Alligon, Isabelle Pellier, Coralie Mallebranche, Jacinta Bustamante, Jérémie Rosain, Capucine Picard, Antoine Néel, Marie Bodinier, Carole Brosseau, Laura Polivka, Christine Bodemer, Caroline Thomas
{"title":"湿疹的先天性免疫错误与特应性:频率,时间,表型聚类。","authors":"Hélène Aubert, Nizar Mahlaoui, Sébastien Barbarot, Mickaël Alligon, Isabelle Pellier, Coralie Mallebranche, Jacinta Bustamante, Jérémie Rosain, Capucine Picard, Antoine Néel, Marie Bodinier, Carole Brosseau, Laura Polivka, Christine Bodemer, Caroline Thomas","doi":"10.1093/bjd/ljag308","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inborn errors of immunity (IEI) with atopy (IEI-A) are a subgroup of IEIs with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEI-A-associated eczema can differ from that of classic AD, and its frequency, genotype-specific clinical patterns and temporal relationships with other manifestations of IEI-A (infections, allergic manifestations, autoimmunity) remain poorly defined.</p><p><strong>Objectives: </strong>To characterize the frequency of eczema, timing and phenotypes in patients with IEI-A, and to explore the relationship of eczema with other clinical manifestations of IEI-A.</p><p><strong>Methods: </strong>This retrospective study used data from the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), focusing on patients with genetically defined IEI-A followed in three large CEREDIH-participating centres and available clinical data. Eczema frequency and onset in relationship to other clinical events, particularly severe-or-unusual infections, was assessed, as were eczema phenotypes, concomitant allergic manifestations, treatments and autoimmunity. Clustering analyses were computed to identify distinct IEI-A eczema-associated clinical phenotypes.</p><p><strong>Results: </strong>Among 373 patients with IEI-A, varying widely by genotype, 50.9% (n = 190) had eczema. All patients deficient in DOCK8 (dedicator of cytokinesis-8) were affected, followed by those deficient in FOXP3 (n = 22/30; 73%) and those with STAT3 loss of function (n = 44/59; 75%). Onset was usually early (median 4 months). Eczema frequency and clinical presentation varied markedly across IEI-A genotypes; four phenotypic clusters were identified, with particular localizations and severe pruritus being strongly associated with pathogenic STAT3 or DOCK8 variants. For children with isolated eczema at 24 months, the risk of developing IEI-related severe or unusual infections was lower than that of persistent isolated eczema until the age of 6.8 years.</p><p><strong>Conclusions: </strong>Eczema is a common, early feature of IEI-A, often preceding infections by years. While 38.4% (n = 73/190) of patients with IEI-A with eczema fulfilled the UK Working Party diagnostic criteria for AD, some clinical pictures may differ from that of classic AD. At a time when systemic AD treatments are rapidly advancing in paediatrics, recognizing these patterns to identify patients with IEI-A could refine diagnostic strategies, improve IEI detection among children with eczema, shorten the time to IEI-A diagnosis, guide tailored management and ensure patients receive the optimal care.</p>","PeriodicalId":520789,"journal":{"name":"The British journal of dermatology","volume":" ","pages":"840-851"},"PeriodicalIF":9.6000,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic clustering.\",\"authors\":\"Hélène Aubert, Nizar Mahlaoui, Sébastien Barbarot, Mickaël Alligon, Isabelle Pellier, Coralie Mallebranche, Jacinta Bustamante, Jérémie Rosain, Capucine Picard, Antoine Néel, Marie Bodinier, Carole Brosseau, Laura Polivka, Christine Bodemer, Caroline Thomas\",\"doi\":\"10.1093/bjd/ljag308\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Inborn errors of immunity (IEI) with atopy (IEI-A) are a subgroup of IEIs with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEI-A-associated eczema can differ from that of classic AD, and its frequency, genotype-specific clinical patterns and temporal relationships with other manifestations of IEI-A (infections, allergic manifestations, autoimmunity) remain poorly defined.</p><p><strong>Objectives: </strong>To characterize the frequency of eczema, timing and phenotypes in patients with IEI-A, and to explore the relationship of eczema with other clinical manifestations of IEI-A.</p><p><strong>Methods: </strong>This retrospective study used data from the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), focusing on patients with genetically defined IEI-A followed in three large CEREDIH-participating centres and available clinical data. Eczema frequency and onset in relationship to other clinical events, particularly severe-or-unusual infections, was assessed, as were eczema phenotypes, concomitant allergic manifestations, treatments and autoimmunity. Clustering analyses were computed to identify distinct IEI-A eczema-associated clinical phenotypes.</p><p><strong>Results: </strong>Among 373 patients with IEI-A, varying widely by genotype, 50.9% (n = 190) had eczema. All patients deficient in DOCK8 (dedicator of cytokinesis-8) were affected, followed by those deficient in FOXP3 (n = 22/30; 73%) and those with STAT3 loss of function (n = 44/59; 75%). Onset was usually early (median 4 months). Eczema frequency and clinical presentation varied markedly across IEI-A genotypes; four phenotypic clusters were identified, with particular localizations and severe pruritus being strongly associated with pathogenic STAT3 or DOCK8 variants. For children with isolated eczema at 24 months, the risk of developing IEI-related severe or unusual infections was lower than that of persistent isolated eczema until the age of 6.8 years.</p><p><strong>Conclusions: </strong>Eczema is a common, early feature of IEI-A, often preceding infections by years. While 38.4% (n = 73/190) of patients with IEI-A with eczema fulfilled the UK Working Party diagnostic criteria for AD, some clinical pictures may differ from that of classic AD. At a time when systemic AD treatments are rapidly advancing in paediatrics, recognizing these patterns to identify patients with IEI-A could refine diagnostic strategies, improve IEI detection among children with eczema, shorten the time to IEI-A diagnosis, guide tailored management and ensure patients receive the optimal care.</p>\",\"PeriodicalId\":520789,\"journal\":{\"name\":\"The British journal of dermatology\",\"volume\":\" \",\"pages\":\"840-851\"},\"PeriodicalIF\":9.6000,\"publicationDate\":\"2026-10-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British journal of dermatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/bjd/ljag308\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British journal of dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bjd/ljag308","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:先天性特应性免疫错误(IEIs-A)是一个IEI亚群,湿疹是一个突出的临床特征,可以模拟特应性皮炎(AD)。然而,IEIs-A相关湿疹可能不同于经典AD,其频率、基因型特异性临床模式以及与其他IEIs-A表现(感染、过敏表现、自身免疫)的时间关系仍不明确。目的:了解IEIs-A患者湿疹发生频率、时间和表型特征,探讨湿疹与IEIs-A其他临床表现的关系。方法:本回顾性研究使用来自法国国家IEI (CEREDIH)注册数据库的数据,重点关注三个大型CEREDIH参与中心和现有临床数据中遗传定义的IEIs-A患者。评估了湿疹的频率和发病与其他临床事件的关系,特别是严重或不寻常的感染,以及湿疹的表型、伴随的过敏表现、治疗和自身免疫。计算聚类分析以确定不同的iei -a -湿疹相关临床表型。结果:373例IEIs-A患者中,50.9%存在湿疹,基因型差异较大。所有细胞动力学-8 (DOCK8)特异性缺陷患者均受影响,其次是叉头盒- p3 (FOXP3)缺陷患者(73.3%),以及信号换能器和转录-1激活因子缺失患者(STAT3-LoF; 74.6%)。发病通常早(中位:4个月)。不同IEIs-A基因型的湿疹频率和临床表现差异显著;鉴定出四个表型簇,特定的局部和严重瘙痒与致病性STAT3或DOCK8变异密切相关。对于24个月时患有孤立性湿疹的儿童,发生iei相关严重或异常感染的风险低于持续孤立性湿疹至6.8岁的风险。结论:湿疹是一种常见的早期IEIs-A特征,通常比感染早几年。虽然38.4%的IEIs-A湿疹患者符合英国工作组对AD的诊断标准,但一些临床表现可能与经典AD不同。在儿科系统AD治疗快速发展的时代,认识这些模式以识别IEI - a患者可以改进诊断策略,提高IEI在湿疹儿童中的检测,缩短诊断时间,指导量身定制的管理,并确保这些患者获得最佳护理。
Eczema in inborn errors of immunity with atopy: frequency, timing and phenotypic clustering.
Background: Inborn errors of immunity (IEI) with atopy (IEI-A) are a subgroup of IEIs with eczema as a prominent clinical feature that can mimic atopic dermatitis (AD). However, IEI-A-associated eczema can differ from that of classic AD, and its frequency, genotype-specific clinical patterns and temporal relationships with other manifestations of IEI-A (infections, allergic manifestations, autoimmunity) remain poorly defined.
Objectives: To characterize the frequency of eczema, timing and phenotypes in patients with IEI-A, and to explore the relationship of eczema with other clinical manifestations of IEI-A.
Methods: This retrospective study used data from the French National Referral Center for Primary Immunodeficiency Diseases (CEREDIH), focusing on patients with genetically defined IEI-A followed in three large CEREDIH-participating centres and available clinical data. Eczema frequency and onset in relationship to other clinical events, particularly severe-or-unusual infections, was assessed, as were eczema phenotypes, concomitant allergic manifestations, treatments and autoimmunity. Clustering analyses were computed to identify distinct IEI-A eczema-associated clinical phenotypes.
Results: Among 373 patients with IEI-A, varying widely by genotype, 50.9% (n = 190) had eczema. All patients deficient in DOCK8 (dedicator of cytokinesis-8) were affected, followed by those deficient in FOXP3 (n = 22/30; 73%) and those with STAT3 loss of function (n = 44/59; 75%). Onset was usually early (median 4 months). Eczema frequency and clinical presentation varied markedly across IEI-A genotypes; four phenotypic clusters were identified, with particular localizations and severe pruritus being strongly associated with pathogenic STAT3 or DOCK8 variants. For children with isolated eczema at 24 months, the risk of developing IEI-related severe or unusual infections was lower than that of persistent isolated eczema until the age of 6.8 years.
Conclusions: Eczema is a common, early feature of IEI-A, often preceding infections by years. While 38.4% (n = 73/190) of patients with IEI-A with eczema fulfilled the UK Working Party diagnostic criteria for AD, some clinical pictures may differ from that of classic AD. At a time when systemic AD treatments are rapidly advancing in paediatrics, recognizing these patterns to identify patients with IEI-A could refine diagnostic strategies, improve IEI detection among children with eczema, shorten the time to IEI-A diagnosis, guide tailored management and ensure patients receive the optimal care.